Prince Akwasi Mensah

Array ( [id] => 1485811 [patent_doc_number] => 06365634 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Naturally occurring compounds and their derivatives as cyclooxygenase 2 and/or 5-lipoxygenase inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/210343 [patent_app_country] => US [patent_app_date] => 1998-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 44 [patent_no_of_words] => 15685 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365634.pdf [firstpage_image] =>[orig_patent_app_number] => 09210343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4238069 [patent_doc_number] => 06166039 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Peripherally active anti-hyperalgesic opiates' [patent_app_type] => 1 [patent_app_number] => 9/199873 [patent_app_country] => US [patent_app_date] => 1998-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29103 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/166/06166039.pdf [firstpage_image] =>[orig_patent_app_number] => 199873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4154103 [patent_doc_number] => 06124304 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Penciclovir for the treatment of zoster associated pain' [patent_app_type] => 1 [patent_app_number] => 9/187660 [patent_app_country] => US [patent_app_date] => 1998-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6541 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/124/06124304.pdf [firstpage_image] =>[orig_patent_app_number] => 187660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4134690 [patent_doc_number] => 06121328 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Racemic propranolol' [patent_app_type] => 1 [patent_app_number] => 9/187334 [patent_app_country] => US [patent_app_date] => 1998-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1253 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121328.pdf [firstpage_image] =>[orig_patent_app_number] => 187334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940511 [patent_doc_number] => 05981552 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Sublingual and buccal compositions of droperidol and method for treating migraine' [patent_app_type] => 1 [patent_app_number] => 9/177996 [patent_app_country] => US [patent_app_date] => 1998-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2093 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981552.pdf [firstpage_image] =>[orig_patent_app_number] => 177996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4208737 [patent_doc_number] => 06028108 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Propofol composition comprising pentetate' [patent_app_type] => 1 [patent_app_number] => 9/176881 [patent_app_country] => US [patent_app_date] => 1998-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2736 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028108.pdf [firstpage_image] =>[orig_patent_app_number] => 176881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4134127 [patent_doc_number] => 06121289 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Method for enhanced brain delivery of nicotinic antagonist' [patent_app_type] => 1 [patent_app_number] => 9/169150 [patent_app_country] => US [patent_app_date] => 1998-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2867 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121289.pdf [firstpage_image] =>[orig_patent_app_number] => 169150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4149699 [patent_doc_number] => 06103274 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Pharmaceutical, orally applicable composition' [patent_app_type] => 1 [patent_app_number] => 9/162574 [patent_app_country] => US [patent_app_date] => 1998-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2931 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103274.pdf [firstpage_image] =>[orig_patent_app_number] => 162574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3944951 [patent_doc_number] => 05990178 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Pharmaceutical compositions suitable for use against histomoniasis' [patent_app_type] => 1 [patent_app_number] => 9/162161 [patent_app_country] => US [patent_app_date] => 1998-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1279 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/990/05990178.pdf [firstpage_image] =>[orig_patent_app_number] => 162161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4082967 [patent_doc_number] => 06054491 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Agent for increasing the production of/in breeding and production mammals' [patent_app_type] => 1 [patent_app_number] => 9/147046 [patent_app_country] => US [patent_app_date] => 1998-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2167 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054491.pdf [firstpage_image] =>[orig_patent_app_number] => 147046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4119484 [patent_doc_number] => 06071962 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Oxa acids and related compounds for treating skin conditions' [patent_app_type] => 1 [patent_app_number] => 9/152574 [patent_app_country] => US [patent_app_date] => 1998-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6952 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071962.pdf [firstpage_image] =>[orig_patent_app_number] => 152574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4184952 [patent_doc_number] => 06150396 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Methods of treating or preventing interstitial cystitis' [patent_app_type] => 1 [patent_app_number] => 9/142780 [patent_app_country] => US [patent_app_date] => 1998-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4856 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150396.pdf [firstpage_image] =>[orig_patent_app_number] => 142780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4086583 [patent_doc_number] => 06025362 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Uses of xanthine compounds' [patent_app_type] => 1 [patent_app_number] => 9/143882 [patent_app_country] => US [patent_app_date] => 1998-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5704 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025362.pdf [firstpage_image] =>[orig_patent_app_number] => 143882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4143752 [patent_doc_number] => 06030992 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Methods of treating or preventing sleep apnea' [patent_app_type] => 1 [patent_app_number] => 9/142026 [patent_app_country] => US [patent_app_date] => 1998-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29642 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 632 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030992.pdf [firstpage_image] =>[orig_patent_app_number] => 142026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4118927 [patent_doc_number] => 06071926 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Sleep quality improvement using a growth hormone secretagogue' [patent_app_type] => 1 [patent_app_number] => 9/125562 [patent_app_country] => US [patent_app_date] => 1998-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 4 [patent_no_of_words] => 7933 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071926.pdf [firstpage_image] =>[orig_patent_app_number] => 125562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4048805 [patent_doc_number] => 05968932 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Method of inhibiting sleep apnea' [patent_app_type] => 1 [patent_app_number] => 9/051859 [patent_app_country] => US [patent_app_date] => 1998-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3203 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968932.pdf [firstpage_image] =>[orig_patent_app_number] => 051859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3944263 [patent_doc_number] => 05990134 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Oral droperidol compositions and method for treating migraine' [patent_app_type] => 1 [patent_app_number] => 9/133106 [patent_app_country] => US [patent_app_date] => 1998-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2403 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/990/05990134.pdf [firstpage_image] =>[orig_patent_app_number] => 133106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4031556 [patent_doc_number] => 05994326 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Anti-atopic dermatitis composition' [patent_app_type] => 1 [patent_app_number] => 9/132267 [patent_app_country] => US [patent_app_date] => 1998-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2351 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994326.pdf [firstpage_image] =>[orig_patent_app_number] => 132267 [rel_patent_id] =>[rel_patent_doc_number] =>)